RecruitingNot ApplicableNCT06547970

Pharmacist Led Educational Intervention on QOL, Medication Adherence & Satisfaction on Patients With Type 1 DM

The Impact of Pharmacist Led Education Program on Glycemic Control, Quality of Life and Medication Adherence Among Patients With Type 1 Diabetes Mellitus


Sponsor

University of Baghdad

Enrollment

60 participants

Start Date

Feb 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

There was no previous study in Iraq to evaluate the efficacy of pharmacist-led educational intervention on patient glycemic control, quality of life and medication adherence among type 1 diabetic patients in Iraq. Improving diabetes patients' information's about their disease control, the role of insulin and the right technique to administer it, how to deal with hyper- and hypoglycemia, about their diet and exercise. It is important to conduct a study to evaluate the pharmacist's role in education and improving patients' quality of life.


Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a pharmacist-led education program can improve quality of life, help patients take their medications correctly, and increase satisfaction for people with Type 1 diabetes (T1DM) who have poorly controlled blood sugar. The pharmacist provides tailored guidance to help patients better understand and manage their condition. **You may be eligible if...** - You are 16 years of age or older - You can speak and read Arabic - You have had Type 1 diabetes for at least 6 months - Your blood sugar is currently not well controlled (high HbA1c or fasting glucose) - Your diabetes medication regimen has stayed the same for the past 3 months - You (or your parent/guardian) agree to participate **You may NOT be eligible if...** - You have hearing, speech, or thinking difficulties that would prevent you from understanding the education sessions - You have other medical conditions that might interfere with the study, such as asthma, thyroid problems, adrenal disorders, celiac disease, or serious kidney problems - You are currently taking corticosteroid medications - Your medication regimen recently changed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREducational intervension

an educational intervention about the disease, symptoms \& how to deal with these symptoms, foot care, life style like sport and nutritional advices


Locations(1)

Al-kindy Specialized center for endocrine diseases and diabetes

Baghdad, Iraq

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06547970


Related Trials